Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Excelerate Health Ventures is a venture capital fund based in the United States, specifically located in the Research Triangle Park area of Durham, North Carolina. Founded by a team of experienced entrepreneurs, the firm is dedicated to early-stage companies in the healthcare sector. The organization emphasizes a hands-on operational approach, aiming to create highly valued healthcare companies that enhance patient outcomes while reducing costs.
The firm primarily invests in capital-efficient healthcare technology and tech-enabled services startups, particularly those leveraging artificial intelligence to transform the pharmaceutical industry. Excelerate Health Ventures has a strong focus on identifying high-potential startups that can scale rapidly, typically targeting companies in the pre-seed, seed, and Series A stages. Their mission is to redefine pharmaceutical technology and services through innovative solutions.
Excelerate Health Ventures has built a diverse portfolio that includes notable companies such as Atalan, BEKHealth, and Censinet. The firm actively engages with the startup ecosystem, demonstrating a strong track record in identifying and supporting high-potential healthcare companies. Their operational support and domain expertise are key components of their investment strategy, allowing them to navigate the complexities of the healthcare landscape effectively.
Excelerate Health Ventures invests in early-stage companies within the healthcare sector, with a particular emphasis on those utilizing artificial intelligence to innovate pharmaceutical technology and services. The firm is stage-agnostic but typically focuses on pre-seed, seed, and Series A investments. Their investment strategy is centered on capital-efficient healthcare technology and tech-enabled services startups that can scale rapidly.
The firm seeks to create the nation's premier AI-Powered Pharma Tech and Services fund, focusing on AI-driven solutions that improve patient outcomes and reduce healthcare costs. Excelerate Health Ventures emphasizes the importance of domain expertise and operational support in its investment strategy, which includes a hands-on approach to help startups navigate the complexities of the healthcare landscape.
Excelerate Health Ventures looks for founders who demonstrate a strong understanding of their market and possess the ability to execute their vision effectively. The firm values speed-to-exit and aims to maximize investment returns, indicating a preference for capital-efficient business models that can achieve successful acquisitions or exits in a timely manner.
Excelerate Health Ventures has built a notable portfolio of companies that exemplify its focus on healthcare technology and AI-driven solutions. Key portfolio companies include:
Several of these companies have achieved successful exits, including Bivarus, CarePort, Diameter Health, and NurseGrid, which was acquired by HealthStream in March 2020. This track record highlights Excelerate Health Ventures' ability to identify and support high-potential startups in the healthcare sector.
Bobby Bahram: Managing Partner at Excelerate Health Ventures, Bobby has extensive experience in the healthcare sector and has been instrumental in leading investments in AI-driven healthcare startups.
Maulik Mehta: Managing Partner, Maulik brings a wealth of knowledge in technology and healthcare investments, focusing on identifying high-potential startups that can scale rapidly.
Andrew Schwab: Managing Partner, Andrew has a strong background in venture capital and operational support, helping portfolio companies navigate the complexities of the healthcare landscape.
Gary Abrahams: Venture Partner, Gary has significant experience in healthcare technology and has played a key role in supporting portfolio companies with operational insights.
Laura Hilty: Venture Partner, Laura specializes in healthcare investments and brings a deep understanding of the industry, contributing to the firm's strategic direction and investment decisions.
To pitch Excelerate Health Ventures, founders should reach out via email at info@exceleratehealth.com. It is important to include a comprehensive overview of the startup, including the business model, market opportunity, and how the company leverages AI in healthcare. A well-structured pitch deck that outlines the team, product, market fit, and financial projections is recommended.
While specific response time expectations are not disclosed, founders should be prepared for a thorough evaluation process. Warm introductions are preferred, as they can facilitate a more favorable review of the pitch. Excelerate Health Ventures values clarity and conciseness in pitches, so founders should aim to communicate their vision effectively.
In February 2022, Excelerate Health Ventures led a $9.5 million Series A investment in Huma.AI, a NoCode knowledge automation platform for pharma and device companies. This investment highlights the firm's commitment to supporting AI-driven healthcare innovations.
In June 2021, the firm led a $4 million Series Seed investment in BEKHealth, an AI-enabled analytics platform designed to accelerate and automate clinical trials. This investment further demonstrates Excelerate's focus on enhancing patient outcomes through technology.
Excelerate Health Ventures has also been involved in financing rounds for other notable companies, including OrbitalRx, which focuses on managing medication shortages. Their active engagement in the startup ecosystem reflects a strong track record in identifying and supporting high-potential healthcare companies.
What investment criteria does Excelerate Health Ventures look for?
Excelerate Health Ventures focuses on early-stage healthcare companies that leverage artificial intelligence to innovate pharmaceutical technology and services. They typically invest in capital-efficient startups at the pre-seed, seed, and Series A stages.
How can I pitch to Excelerate Health Ventures?
Founders can pitch their startups by reaching out via email at info@exceleratehealth.com. It is advisable to include a detailed overview of the business model, market opportunity, and how the startup leverages AI in healthcare.
What makes Excelerate Health Ventures different from other VC firms?
Excelerate Health Ventures emphasizes a hands-on operational approach and domain expertise, providing significant operational support to its portfolio companies. Their focus on AI-driven solutions in healthcare sets them apart in the venture capital landscape.
What is the geographic focus of Excelerate Health Ventures?
The firm primarily invests in companies based in the United States, particularly those within the healthcare sector.
What is the typical check size for investments?
Specific check sizes are not publicly disclosed, but Excelerate Health Ventures typically targets early-stage companies raising their first institutional round.
What kind of post-investment involvement can founders expect?
Excelerate Health Ventures provides operational support and domain expertise to its portfolio companies, leveraging a network of pharma, provider, payer, and strategic partners to help validate and grow their businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.